Ediz Dalkılıç

1.5k total citations
72 papers, 494 citations indexed

About

Ediz Dalkılıç is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Ediz Dalkılıç has authored 72 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Rheumatology, 18 papers in Immunology and 14 papers in Hematology. Recurrent topics in Ediz Dalkılıç's work include Rheumatoid Arthritis Research and Therapies (28 papers), Spondyloarthritis Studies and Treatments (18 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). Ediz Dalkılıç is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (28 papers), Spondyloarthritis Studies and Treatments (18 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). Ediz Dalkılıç collaborates with scholars based in Türkiye, United States and Finland. Ediz Dalkılıç's co-authors include Yavuz Pehlivan, Belkıs Nihan Coşkun, Sevil Kamalı, Murat İnanç, Nevsun İnanç, Haner Di̇reskeneli̇, Ayşe Çefle, Esen Kasapoğlu Günal, Orhan Aral and Meral Koniçe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Ediz Dalkılıç

58 papers receiving 485 citations

Peers

Ediz Dalkılıç
Chengappa Kavadichanda India
Marco Fornaro Italy
Cássia Maria Passarelli Lupoli Barbosa Brazil
Elżbieta Smolewska Poland
Graciela Espada Argentina
Petra Król Sweden
William Shomali United States
Peer Aries Germany
Juan José Alegre Sancho Spain
Padmanabha Shenoy India
Chengappa Kavadichanda India
Ediz Dalkılıç
Citations per year, relative to Ediz Dalkılıç Ediz Dalkılıç (= 1×) peers Chengappa Kavadichanda

Countries citing papers authored by Ediz Dalkılıç

Since Specialization
Citations

This map shows the geographic impact of Ediz Dalkılıç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ediz Dalkılıç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ediz Dalkılıç more than expected).

Fields of papers citing papers by Ediz Dalkılıç

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ediz Dalkılıç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ediz Dalkılıç. The network helps show where Ediz Dalkılıç may publish in the future.

Co-authorship network of co-authors of Ediz Dalkılıç

This figure shows the co-authorship network connecting the top 25 collaborators of Ediz Dalkılıç. A scholar is included among the top collaborators of Ediz Dalkılıç based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ediz Dalkılıç. Ediz Dalkılıç is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kandemir, Özge, Sefa Küçükler, Selçuk Özdemir, et al.. (2025). Protective Effects of Quercetin Against Vincristine‐Induced Nephrotoxicity via Modulation of Oxidative Stress, Inflammation, and Apoptosis in Rats. Journal of Biochemical and Molecular Toxicology. 39(9). e70516–e70516.
3.
Albayrak, Fatih, Bünyamin Kısacık, Süleyman Serdar Koca, et al.. (2025). Idiopathic granulomatous mastitis: TNFi effectivity in a retrospective inception cohort. Clinical Rheumatology. 44(6). 2553–2560.
4.
Coşkun, Belkıs Nihan, et al.. (2024). Pan-Immune-Inflammation Value Could Be a New Marker to Predict Amyloidosis and Disease Severity in Familial Mediterranean Fever. Diagnostics. 14(6). 634–634. 1 indexed citations
5.
Çefle, Ayşe, Sema Yılmaz, Süleyman Serdar Koca, et al.. (2024). Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study. Scientific Reports. 14(1). 14194–14194. 5 indexed citations
6.
Coşkun, Belkıs Nihan, et al.. (2024). The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey. Diagnostics. 14(19). 2205–2205. 1 indexed citations
7.
Çefle, Ayşe, Fatoş Önen, Nurullah Akkoç, et al.. (2024). Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results. Archives of Rheumatology. 39(2). 232–241. 4 indexed citations
8.
Coşkun, Belkıs Nihan, et al.. (2024). α9β1 integrin & its ligands as new potential biomarkers in FMF. The Indian Journal of Medical Research. 160(1). 102–108.
9.
10.
Coşkun, Belkıs Nihan, et al.. (2023). Biological Agent Use in Behçet's Patients Who Are Resistant to Conventional Treatments: A Multidisciplinary Retrospective Study. Bursa Uludag University - AVESIS. 5(1). 33–40.
11.
Akar, Servet, Ediz Dalkılıç, Berna Göker, et al.. (2023). The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis. TURKISH JOURNAL OF MEDICAL SCIENCES. 53(4). 970–978.
12.
13.
Coşkun, Belkıs Nihan, Ahmet Omma, Alper Sarı, et al.. (2021). Predictors for the risk and severity of post-thrombotic syndrome in vascular Behçet's disease. Journal of Vascular Surgery Venous and Lymphatic Disorders. 9(6). 1451–1459. 13 indexed citations
14.
Solmaz, Dilek, Umut Kalyoncu, Ilaria Tinazzi, et al.. (2019). Current Smoking Is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis. The Journal of Rheumatology. 47(9). 1354–1358. 4 indexed citations
15.
Can, G., Ayşe Çefle, Sema Yılmaz, et al.. (2019). FRI0416 THE EFFICACY AND SAFETY OF ANTI-TNF A TREATMENT IN ANKYLOSING SPONDYLITIS PATIENTS WITH LATE ONSET COMPARED TO THOSE WITH ADULT ONSET; THE DATA FROM TURKBIO REGISTRY. Annals of the Rheumatic Diseases. 78. 896–896. 1 indexed citations
16.
Dalkılıç, Ediz, et al.. (2015). Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers. European Journal of Rheumatology. 2(2). 62–65. 4 indexed citations
17.
Dalkılıç, Ediz & Belkıs Nihan Coşkun. (2014). Sjögren sendromunda sinir sistemi tutulumu ve vaskülit. 6(2). 62–66. 1 indexed citations
18.
Dalkılıç, Ediz, et al.. (2012). Interlökin-6: Inflamasyonda Başrol Oyuncularından. DergiPark (Istanbul University). 38(2). 157–160. 1 indexed citations
19.
Dalkılıç, Ediz, et al.. (2011). Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases. Modern Rheumatology. 22(3). 463–466. 4 indexed citations
20.
İnanç, Nevsun, Ediz Dalkılıç, Sevil Kamalı, et al.. (2006). Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clinical Rheumatology. 26(1). 17–23. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengappa Kavadichanda Breakdown of academic impact, for papers by Marco Fornaro Breakdown of academic impact, for papers by Cássia Maria Passarelli Lupoli Barbosa Breakdown of academic impact, for papers by Elżbieta Smolewska Breakdown of academic impact, for papers by Graciela Espada Breakdown of academic impact, for papers by Petra Król Breakdown of academic impact, for papers by William Shomali Breakdown of academic impact, for papers by Peer Aries Breakdown of academic impact, for papers by Juan José Alegre Sancho Breakdown of academic impact, for papers by Padmanabha Shenoy
Rankless by CCL
2026